ArticleAbdominal radiology (New York)2026
Impact of perirenal collateral on the surgical management and prognosis of nonmetastatic renal cell carcinoma and inferior vena cava tumor thrombus.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purposeTo explore the influence of perirenal collateral (PRC) on the operation and prognosis of nonmetastatic renal cell carcinoma (RCC) and inferior vena cava (IVC) tumor thrombus.
methodsA total of 10,260 patients with RCC who underwent surgical resection were retrospectively collected. Two hundred and forty-one patients (median age, 56.0 years [IQR: 48.0, 63.0], 174 males) with pathologically confirmed nonmetastatic RCC and IVC tumor thrombus were analyzed. The presence or absence of abnormal PRC was determined by 3 observers on images. Relevant clinical data, details of the operation, postoperative complications, and pathological results were obtained and compared. The Kaplan-Meier method was used to estimate recurrence-free survival (RFS).
resultsA total of 185 patients had abnormal PRC on preoperative MR images. Patients with abnormal PRC had significantly larger tumor sizes (P < 0.001), were more likely to have clinical symptoms (P < 0.001), and had positive RBCs in urine (P < 0.001). During the operation, patients with abnormal PRC had a longer operative duration (P < 0.001), more blood loss (P < 0.001), and more red blood cell infusions (P = 0.002). Compared with patients without abnormal PRC, the proportion of open surgery was significantly higher in patients with abnormal PRC (44/185 vs. 5/56, P = 0.001). RFS was significantly shorter (P = 0.002) among patients with abnormal PRC. By multivariate Cox regression analysis, renal sinus fat invasion, perirenal fat invasion, tumor size, and abnormal PRC were independent predictors of RFS (all P < 0.05).
conclusionIn patients with nonmetastatic RCC and IVC tumor thrombus, abnormal PRC was associated with intraoperative adverse events and worse RFS. Evaluation of PRC through imaging could help develop treatment plans and provide prognostic information.
Indexed as
Identifiers
40715518What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.